Roche, Bio-Techne extend collaboration over mRNA ISH tissue analysis
Category: #health  By Mateen Dalal  Date: 2019-05-07
  • share
  • Twitter
  • Facebook
  • LinkedIn

Roche, Bio-Techne extend collaboration over mRNA ISH tissue analysis

Roche’s new detection kits have more translucent dyes which are suited for mRNA ISH co-localization studies

Swiss healthcare company Roche has recently announced that it has expanded its collaboration with Bio-Techne by providing drug discovery researchers in the U.S. with novel chromogenic detection kits for ISH (in situ hybridization) tissue analysis.

Apparently, the novel Roche kits are comprised of the DISCOVERY mRNA Purple HRP and Teal HRP detection kits. Both the teal and purple detection kits have more translucent dyes which are suited for mRNA ISH co-localization studies and feature the ability to perform ISH and immunohistochemistry (IHC) for co-detecting protein-RNA on same slides.

Citing reliable sources, designs of both these kits are aimed for using on Roche’s staining platform DISCOVERY ULTRA along with the enhanced signal-to-noise ratio and robustness of its newly released ACD RNAscope VS Universal HRP Reagent Kit.

Sources informed that mRNA Duplex AMP kit from Roche now has an extended application that allows dual mRNA ISH detection by using the latest mRNA Teal detection kit with the already available mRNA RED detection kit.

The red & teal combination offers a different visual contrast and the teal dye’s translucency enables the studying of mRNA ISH marks co-expressions, where the subsequent red and teal dyes overlap to create an indigo color. This new application is proposed for use with the newly launched RNAscope VS Duplex Reagent Kit that allows real-time in situ detection of two mRNA species.

Seemingly, the dual mRNA ISH application and new detection kits allow researchers to raise their multiplexing possibilities, while optimizing staining conditions for challenging probes and antibodies, conserving tissue samples, saving time and easily running complex assays.

Automating IHC and ISH on the DISCOVERY ULTRA platform allows scientists to create reproducible, standardized results and remove more than 90% of manual processes so that they can devote more time focusing on their research part, sources commented.

Source Credit: https://www.biospace.com/article/releases/roche-expands-partnership-with-bio-techne-to-offer-drug-discovery-researchers-new-chromogenic-detection-options-for-mrna-ish-tissue-analysis/

  • share
  • Twitter
  • Facebook
  • LinkedIn


About Author

Mateen Dalal    

Mateen Dalal

Mateen has completed his Bachelor’s degree in electronics and telecommunication engineering, post which he lent his proficiency to the industry, working as a quality and test engineer. Drawn intricately toward the field of content creation however, Mateen soon switc...

Read More

More News By Mateen Dalal

TPG Rise Climate Fund raises $5.4Bn to support new climate solutions
TPG Rise Climate Fund raises $5.4Bn to support new climate solutions
By Mateen Dalal

TPG Rise Climate Fund, the climate investing fund of TPG’s global impact investing platform TPG Rise, has recently raised its first close of $5.4 billion, bringing together an exclusive blend of funding from some of the top institutional invest...

Baby nutrition firm ByHeart nabs $90Mn in Series B funding round
Baby nutrition firm ByHeart nabs $90Mn in Series B funding round
By Mateen Dalal

ByHeart, a fully integrated infant nutrition company, has reportedly secured $90 million in Series B funding which the company plans to use for the launch of its baby formula and support the development of its pipeline of nutrition items for chi...

UAE extends travel ban for Indians amid strict COVID-19 guidelines
UAE extends travel ban for Indians amid strict COVID-19 guidelines
By Mateen Dalal

United Arab Emirates (UAE) has reportedly extended travel ban for individuals travelling from India and several other south Asian countries on the pretext of COVID-19 guidelines. As reported by Etihad Airlines, the ban will be followed till 31st July...